Download PDF
Thromb Haemost 2013; 109(01): 195-196
DOI: 10.1160/TH13-02-0111
Letters to the Editor
Schattauer GmbH

Dietary vitamin K intake and anticoagulation control during the initiation phase of warfarin therapy: A prospective cohort study

Ron C. Li
1   Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
5   Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA
,
Brian S. Finkelman
1   Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
2   Center for Therapeutic Effectiveness Research, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
,
Jinbo Chen
1   Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
,
Sarah L. Booth
3   Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Philadelphia, Pennsylvania, USA
,
Luanne Bershaw
1   Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
2   Center for Therapeutic Effectiveness Research, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
,
Colleen Brensinger
1   Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
,
Stephen E. Kimmel
1   Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
2   Center for Therapeutic Effectiveness Research, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
4   Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
› Author Affiliations Financial support: This work was supported by NIH grant R01HL066176, a grant from the Doris Duke Charitable Foundation, and the USDA, Agricultural Research Service under Cooperative Agreement No. 58–1950–7–707. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the authors, and do not necessarily reflect the view of the USDA or the National Institutes of Health.
Further Information

Publication History

Received: 09 February 2013

Accepted after minor revision: 11 March 2013

Publication Date:
30 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Rombouts EK, Rosendaal FR, Van der Meer FJM. Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy. Br J Haematol 2010; 149: 598-605.
    CrossrefPubMedGoogle Scholar
  • 2 Sconce E, Khan T, Mason J. et al. Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation. Thromb Haemost 2005; 93: 872-875.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Pedersen F, Hamberg O, Hess K. et al. The effect of dietary vitamin K on warfarin-induced anticoagulation. J Intern Med 1991; 229: 517-520.
    CrossrefPubMedGoogle Scholar
  • 4 Ansell J, Hirsh J, Hylek E. et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (8th Edition). Chest 2008; 133 (06) Suppl: 160S-198S.
    CrossrefPubMedGoogle Scholar
  • 5 Platt AB, Localio AR, Brensinger CM. et al. Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Chest 2009; 137: 883-889.
    PubMedGoogle Scholar
  • 6 Couris RR, Tataronis GR, Booth SL. et al. Development of a self-assessment instrument to determine daily intake and variability of dietary vitamin K. J Am Coll Nutr 2000; 19: 801-807.
    CrossrefPubMedGoogle Scholar
  • 7 Rosendaal F, Cannegieter S, Van der Meer F. et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-239.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Palareti G, Cosmi B. Bleeding with anticoagulation therapy who is at risk, and how best to identify such patients. Thromb Haemost 2009; 102: 268-278.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Booth SL, Centurelli M. Vitamin K: a practical guide to the dietary management of patients on warfarin. Nutrition Rev 1999; 57: 288-296.
    PubMedGoogle Scholar
  • 10 Johnson M. Influence of Vitamin K on Anticoagulant Therapy Depends on Vitamin K Status and the Source and Chemical Forms of Vitamin K. Nutrition Rev 2005; 63: 91-100.
    CrossrefPubMedGoogle Scholar
  • 11 Warren Grant Magnuson Clinical Center. National Institutes of Health Drug Interaction Task Force. Important information to know when you are taking: Coumadin® and vitamin K. 2003 Available at: http://ods.od.nih.gov/pubs/factsheets/coumad-in1.pdf
    PubMedGoogle Scholar
  • 12 Thane CW, Paul aa, Bates CJ, Bolton-Smith C, Prentice A, Shearer MJ. Intake and sources of phylloquinone (vitamin K1): variation with sociodemographic and lifestyle factors in a national sample of British elderly people. Br J Nutr 2007; 87: 605.
    PubMedGoogle Scholar
  • 13 Sconce E, Avery P, Wynne H. et al. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 2007; 109: 2419-2423.
    CrossrefPubMedGoogle Scholar